A Randomized, Multicenter, Open Label Study of MM-302 plus Trastuzumab vs. Chemotherapy of Physician's Choice plus Trastuzumab in Anthracycline Naive Patients with Locally Advanced/Metastatic HER2-Positive Breast Cancer

  • Santa-Maria, Cesar Augusto (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date5/22/155/22/18

Funding

  • Clintrax Global, Inc. (MM-302-02-02-03)
  • Merrimack Pharmaceuticals, Inc (MM-302-02-02-03)